<img alt="" src="https://secure.perk0mean.com/184504.png" style="display:none;">

4G Clinical

Blog

5 Questions You Never Ask Your RTSM Vendor, But Should

4G Clinical

 

If you are looking for innovation and better results for your trial, the selection process itself should ensure that the vendor shares the same vision. How do you do that? By asking the right questions. Here are 5 to get you started.

Direct-to-Patient (DtP) in Review – What Would We Have Done Differently if We Knew COVID-19 was Coming?

4G Clinical

 

It's been 6 months since COVID-19 was declared a pandemic. Without a vaccine, there is a probability of a second wave. How can we apply what we've learned so far to help us prepare for the future?

5 Supply Chain Impacts Resulting from Master Protocol Amendments – And How to Prepare

4G Clinical

 

With complex oncology studies, mid-study changes are the norm, but disruptions from downstream impacts don’t have to be. Here are 5 supply chain impacts resulting from master protocol amendments– and how to best prepare.

3 Simple Steps to Manage Multiple Protocol Versions in a Single Study

4G Clinical

 

With master protocols, each site has to perform its own approval process in order to begin working under a new protocol version, resulting in multiple protocol versions being used at the same time. How can you manage this? Here are 3 simple steps.

Master Protocol Studies – A Map to an Unknown Destination

4G Clinical

 

A master protocol acts like a map showing many paths a clinical trial may take, where the sponsors don’t know in which direction their study will evolve, until the trial is under way.

The Site Perspective: COVID-19 and the movement towards Direct-to-Patient trials

4G Clinical

 

Q&A with a clinical research site discussing COVID-19 and the movement towards Direct-to-Patient trials.

Is Now The Right Time To Switch To Direct-to-Patient (DtP) Trials?

4G Clinical

 

Direct-to-Patient (DtP) trials are more prevalent than ever before. Here are 5 questions to ask yourself when planning a DtP trial.

A Lung Cancer Patient & Clinical Trial Participant Weighs in on COVID-19

4G Clinical

 

Hear a patient's perspective on the impact of COVID-19 on immunocompromised clinical trial participants and how industry may be able to help.

Industry Calls for Improved Clinical Supply Forecasting Solution

4G Clinical

 

In this interview, two senior industry clinical trial supply professionals discuss experiences with manual tools and existing commercial solutions, as well as the need for an improved clinical supply forecasting solution.

The Ultimate Guide To Scenario Planning Clinical Supply Decisions

4G Clinical

 

Scenario planning is not just comparing two detailed data sets. To be meaningful, it must explore possible outcomes based on a specific combination of events while balancing risks and costs. With so many variables, how do you inform the best strategy? Here is our ultimate guide to scenario planning clinical supply decisions.